Cited 0 time in
Risk of atrial fibrillation development of sodium-glucose co-transporter 2 inhibitor and thiazolidinedione treatment among patients with type 2 diabetes
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Y. R. | - |
| dc.contributor.author | Lee, S. E. | - |
| dc.contributor.author | Kim, K. A. | - |
| dc.date.accessioned | 2023-04-27T15:41:06Z | - |
| dc.date.available | 2023-04-27T15:41:06Z | - |
| dc.date.issued | 2021-10 | - |
| dc.identifier.issn | 0195-668X | - |
| dc.identifier.issn | 1522-9645 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/4417 | - |
| dc.format.extent | 1 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | OXFORD UNIV PRESS | - |
| dc.title | Risk of atrial fibrillation development of sodium-glucose co-transporter 2 inhibitor and thiazolidinedione treatment among patients with type 2 diabetes | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.wosid | 000720456900415 | - |
| dc.identifier.bibliographicCitation | EUROPEAN HEART JOURNAL, v.42, pp 460 - 460 | - |
| dc.citation.title | EUROPEAN HEART JOURNAL | - |
| dc.citation.volume | 42 | - |
| dc.citation.startPage | 460 | - |
| dc.citation.endPage | 460 | - |
| dc.type.docType | Meeting Abstract | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
| dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
